在行为变体前性痴呆症中,层状退化的细胞架构梯度
Daniel T Ohm1,2, Sharon X Xie3, Noah Capp1,2
1Digital Neuropathology Laboratory, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Brain : a journal of neurology
|August 9, 2024
概括
行为变异前性痴呆症 (bvFTD) 显示出不同的神经退行模式. 陶氏病理 (bvFTD-tau) 导致沿着前沿梯度的渐进式金字塔神经元损失,与TDP-43病理 (bvFTD-TDP) 不同.
科学领域:
- 神经科学是一个神经科学.
- 神经病理学神经病理学
- 神经解剖学是一个神经解剖学.
背景情况:
- 行为变异前性痴呆症 (bvFTD) 是一种与tau (bvFTD-tau) 或TDP-43 (bvFTD-TDP) 蛋白质病变相关的综合征.
- 之前的研究表明,与TDP-43相比,在皮层下层和背侧区域的积累较大.
- 跨多种bvFTD细胞架构的层状神经退行模式仍未得到充分研究.
研究的目的:
- 为了调查bvFTD-tau和bvFTD-TDP沿前皮层梯度的金字塔神经退行症的明显分层分布.
- 为了测试bvFTD亚型表现出与细胞架构组织相关的差异性神经退行模式的假设.
主要方法:
- 在bvFTD-tau (n=27),bvFTD-TDP (n=47) 和对照组 (n=32) 中检查了前叶皮层梯度 (从periallocortex到eulaminate-II同皮层).
- 通过使用免疫染色来量化神经元 (NeuN) 和金字塔神经元 (SMI32) 在皮质层 (I-VI) 的免疫活性.
- 采用线性混合效应模型来比较SMI32损失,分析与皮质梯度,远程途径和临床症状的关系.
主要成果:
- bvFTD-TDP显示在皮层梯度沿线均的SMI32损失.
- 在梯度上,bvFTD-tau 呈现出逐渐的 SMI32 损失,在超细粒体欧酸盐-II 异皮质中损失更大.
- 减少SMI32与行为严重程度和前部介导流性相关,而不是时间介导命名.
结论:
- 金字塔神经元损失是bvFTD的临床相关特征,在bvFTD-tau的前沿梯度恶化,但不是bvFTD-TDP.
- 陶介导退化优先影响连接遥远的cytoarchitectonic区域的金字塔丰富的层.
- 皮层梯度为理解bvFTD亚型中的差异性细胞和途径参与提供了一个神经解剖学框架.
相关概念视频
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...


